Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


NIOSH Radiation Dose Reconstruction Program


Section Navigation
			
			CDC Home








alert icon
            Cybersecurity Modernization Initiative
                We are taking steps to continue to modernize and secure our data, applications, and systems. We completed the first phase and restored many of the functions put on pause in May 2021. Now that the first phase is complete, work will resume at a slower pace but will speed up as new systems and applications are brought online. For more information and updates, please visit our Cybersecurity Modernization Initiative web page.
								

				Texas City Chemicals, Inc.						Print
																Related Pages
										On This Page
			Special Exposure CohortWorker Outreach ActivitiesAdvisory Board Work GroupTechnical DocumentsAdvisory Board and NIOSH DiscussionsPublic CommentsDocument Archive
		
(Site Profile/Docket Number 112)
Location: Texas City, Texas
Also known as: American Oil Co., Borden, Inc., Smith-Douglass, Amoco Chemical Company
Special Exposure Cohort Petition Information
The Special Exposure Cohort (SEC) is a unique category of employees established by the Act (42 CFR Part 83). Claims compensated under the SEC do not have to go through the dose reconstruction process. To qualify for compensation under the SEC, a covered employee must meet specific requirements (e.g., must have at least one of 22 “specified cancers,” and have worked for a specified time period at one of the SEC sites). Classes of employees and work sites can be considered for addition to the SEC through a NIOSH petition process. More information about the Special Exposure Cohort can be found on our Frequently Asked Questions page.
Open/Active SEC Petitions
To date, there are no open/active SEC petitions from Texas City Chemicals, Inc..
Class(es) Added to the SEC
All Atomic Weapons Employer employees who worked at Texas City Chemicals, Inc., from October 5, 1953, through September 30, 1955, for a number of work days aggregating at least 250 work days, occurring either solely under this employment or in combination with work days within the parameters established for one or more other classes of employees included in the Special Exposure Cohort.
**Note:** This class was established from Petition 88.
Petitions Qualified for Evaluation
Below is a list of the petitions that qualified for evaluation. Select a petition on the list to view the table for that particular petition.Petition 88 (Jan 1, 1952 to Dec 31, 1956)
	Petition 88
Steps in Petition Process:
Petition Details:Date Received
March 13, 2007Date Qualified for Evaluation
August 17, 2007Summary of Information in Petition
**Location:** Texas City, Texas
**Job Titles and/or Job Duties:** All employees
**Period of Employment:** January 1, 1952 through December 31, 1956
**Note:** The information above is what qualified for evaluation. During our evaluation of whether dose reconstructions can adequately be completed for the above job titles and period of employment, information may cause NIOSH to change some the dates or job titles/duties. Therefore, as this petition proceeds through the SEC petition process and if an SEC class is proposed, the proposed class may not exactly match the above information.Copy of the Petition Received
March 13, 2007 [551 KB (10 pages)](January 1, 1948 through December 31, 1956)Federal Register Notice Announcing that a Texas City Chemicals SEC Petition has met the Minimum Qualifications for Review and Evaluation
August 28, 2007 [41 KB (1 page)](January 1, 1952 through December 31, 1956)SEC Petition Evaluation Report
Revised October 19, 2010 [450 KB (64 pages)](October 5, 1953 through September 30, 1955)Evaluation Report Sent to the Advisory Board
October 25, 2010 (Revision 1)(October 5, 1953 through September 30, 1955)Petition Discussed by the Advisory Board
The Advisory Board discussed the petition on November 17, 2010; April 7, 2008; and June 26, 2008, during its regular meetings.
**Note:** Agendas and transcripts for Board meetings will be posted on the Advisory Board and Public Meetings page as soon as they become available.Advisory Board Recommendation on SEC Petition
December 8, 2010 [33 KB (2 pages)] (October 5, 1953, through September 30, 1955)HHS Letters to Congress Regarding the SEC Petition
January 6, 2011 [75 KB (9 pages)] (October 5, 1953, through September 30, 1955)HHS Designation/Determination of Additional Members to the SEC
**Designation:**
January 6, 2011 [33 KB (4 pages)] (October 5, 1953, through September 30, 1955)
**Note:** A “designation” means that HHS is recommending a class be added to the SEC. A “determination” means that HHS is recommending a class **not** be added to the SEC.Federal Register Notice: Designation/Determination of a Class of Employees for Addition to the Special Exposure Cohort
**Designation:**
January 21, 2011 [41 KB (1 page)] (October 5, 1953, through September 30, 1955)
**Note:** A “designation” will be published if there is a recommendation to add a class to the SEC. A “determination” will be published if there is a recommendation **not** to add a class to the SEC.Effective Date for the SEC Class
February 5, 2011 (October 5, 1953, through September 30, 1955)
**Note:** This only applies if the class is added to the SEC.Federal Register Notice: Final Effect of Designation of a Class of Employees for Addition to the Special Exposure Cohort
February 11, 2011 [49 KB (1 page)] (October 5, 1953, through September 30, 1955)
**Note:** This only applies if the class is added to the SEC.Letter to DOL Regarding the Addition of a New Class of Employees to the SEC
February 7, 2011 [18 KB (1 page)] (October 5, 1953, through September 30, 1955)
**Note:** This only applies if the class is added to the SEC.
SEC Petitions Not Qualifying for Evaluation
There was one additional petition received but it did not qualify for evaluation. The petition did not meet the minimum petition requirements for evaluation.
Worker Outreach Activities
Based on a recommendation from the Advisory Board to provide workers and site experts with opportunities to participate in developing the technical documents used in dose reconstruction, NIOSH established a Worker Outreach Program.
At Worker Outreach Meetings, current and former DOE and AWE employees have opportunities to obtain information about Site Profiles, Technical Basis Documents, and Technical Information Bulletins, and to provide information for consideration and possible use in dose reconstruction. This process is valuable to ensure that the technical documents used in dose reconstruction contain correct and useful information.
Below are the Worker Outreach Activities for the Texas City Chemicals, Inc.:
**November 15, 2007**
            Town Hall Meeting on Texas City Chemicals, Inc.Captain’s Room of the Nessler Center2010 5th Avenue NorthTexas City, Texas
            7:00 p.m. to 9:00 p.m.
            Former workers, as well as family members, are invited and encouraged to attend.
            Purpose: This meeting is an opportunity for former workers, and their families, to hear about NIOSH’s responsibilities under Part B of EEOICPA, including its dose reconstruction program and the SEC petition process. Please note this meeting is not an opportunity to discuss individual claim status; however, representatives from NIOSH and the Department of Labor will be available to answer general questions related to EEOICPA.Minutes [38 KB (8 pages)]
**October 18, 2007**
            Meeting with former workers International Union of Operating Engineers Local 564 Hall Texas City, Texas
            Final Minutes
2:00 p.m. meeting [75 KB (23 pages)]
7:00 p.m. meeting [51 KB (14 pages)]Advisory Board Work Group on Texas City Chemicals, Inc.
This Work Group will consider the conditions under which “surrogate” data can be used as a valid substitute for actual data for a given site. The Work Group will seek to establish the type and importance of various parameters (e.g., type of nuclide, amounts of material, chemical and physical forms, processes, working conditions, and other such parameters) that impact on worker dose, and will consider the extent to which such parameters at one site may apply to other sites. The Work Group may also consider the extent to which theoretical considerations can be properly used to bound dosed in the absence of actual workplace measurements. The Work Group should strive to develop a policy recommendation that can be adopted by the Board regarding the use of surrogate data. This Work Group was asked to consider the application of surrogate data criteria to the Texas City Chemicals, Inc., site in relation to the SEC petition for that facility.
Work Group Members:
James Malcolm Melius, M.D., Dr. P.H. (Chair)
Josie Beach
James E. Lockey, M.D., M.S.
Wanda I. MunnMeeting Information:
**November 5, 2010**
            Teleconference Meeting of the Advisory Board’s Work Group on the Use of Surrogate Data
            Time/Location:
1:00 p.m. Eastern Standard Time (EST)
                Meeting Type: Teleconference; Public, No Comment Period
                Teleconference: +1-866-659-0537
                Participant Code: 9933701Pre-Decisional Document Policy
Available Meeting Items:
Agenda [9 KB (1 page)]
Transcript [185 KB (62 pages)]
**May 13, 2010**
            Teleconference Meeting of the Advisory Board’s Work Group on the Use of Surrogate Data
            Time/Location:
1:00 p.m. Eastern Standard Time (EST)
                Meeting Type: Teleconference; Public, No Comment Period
                Teleconference: +1-866-659-0537
                Participant Code: 9933701Pre-Decisional Document Policy
Available Meeting Items:
Agenda [45 KB (1 page)]
Transcript [126 KB (69 pages)]
**January 11, 2010**
            Teleconference Meeting of the Advisory Board’s Work Group on the Use of Surrogate Data
1:00 p.m. Eastern Standard Time (EST)
                Meeting Type: Teleconference; Public, No Comment Period
                Teleconference: +1-866-659-0537
                Participant Code: 9933701Pre-Decisional Document Policy
Available Meeting Items:
An agenda will be provided at a later date.
Transcript [194 KB (92 pages)]
**May 8, 2009**
            Teleconference Meeting of the Advisory Board’s Work Group on the Use of Surrogate Data
            Time/Location:
1:00 p.m. Eastern Standard Time (EST)
                Meeting Type: Teleconference; Public, No Comment Period
                Teleconference: +1-866-659-0537
                Participant Code: 9933701Pre-Decisional Document Policy
Available Meeting Items:
Agenda [15 KB (1 page)]
Transcript [107 KB (59 pages)]
**June 9, 2008**
            Teleconference Meeting of the Advisory Board’s Work Group on Surrogate Data
            Time/Location:
11:30 a.m. Eastern Standard Time (EST)
                Meeting type: Teleconference; Open to Public; No Public Comment Period
                Teleconference: +1-866-659-0537
                Participant Code: 9933701Pre-Decisional Document Policy
Available Meeting Items:
An agenda will be provided at a later date.
Transcript [133 KB (34 pages)]Pre-Decisional Document Policy
Please note that as part of the procedures and processes of the Advisory Board’s Work Groups, several kinds of pre-decisional documents may be developed. These pre-decisional documents, such as white papers, matrices, working drafts, etc., are distributed among Work Group members as research and background tools to facilitate discussion and deliberation. Although discussion during a public meeting may cover pre-decisional documents, these documents often are not further revised or finalized, and thus do not reflect the final determination or evaluation of the Advisory Board and its Work Groups. Additionally, some pre-decisional documents not otherwise posted on the website may contain sensitive information, which would require an interested party to obtain such documents by filing a Freedom of Information Act (FOIA) request with the CDC/ATSDR FOIA office at foiarequests@cdc.gov.
Technical Documents
If the energy employee’s personal radiation information is incomplete, NIOSH will use other sources to estimate the radiation dose. This may involve using technical documents called Site Profiles, Technical Basis Documents, and Technical Information Bulletins.

Technical Basis Documents
Technical Basis Document for Texas City Chemicals, Inc. Texas City, Texas [315 KB (24 pages)]
                April 27, 2020Advisory Board and NIOSH Comments and Discussion Papers on Texas City Chemicals, Inc.
The Texas City Chemicals, Inc. discussion papers listed below are working documents prepared by NIOSH or its contractor for use in discussions with the Advisory Board on Radiation and Worker Health or its Working Groups or Subcommittees. Draft, preliminary, interim, and white paper documents are not final NIOSH or Advisory Board (or their technical support and review contractors) positions unless specifically marked as such. These documents represent preliminary positions taken on technical issues prepared by NIOSH or its contractor.
The discussion papers have been reviewed to identify and redact any information that is protected by the Privacy Act 5 USC §552a and have been cleared for distribution.
SC&A Presentation: Review of NIOSH’s Program Evaluation Report DCAS-PER-093, “Texas City Chemicals” [301 KB (17 pages)]
            Presentation at the February 16, 2023, Teleconference Meeting of the Subcommittee for Procedure Reviews
SC&A Presentation: Review of NIOSH’s Program Evaluation Report DCAS-PER-093, “Texas City Chemicals” [243 KB (12 pages)]
            Presentation at the September 29, 2022, Teleconference Meeting of the Subcommittee for Procedure Reviews
SC&A Draft: A Review of NIOSH’s Program Evaluation Report DCAS PER 093, “Texas City Chemicals, TBD Rev. 01” [586 KB (14 pages)]
                Contract No. 75D30119C04183
                Document No. SCA-TR-2022-PER093, Revision 0
                May 5, 2022
SC&A Draft: Evaluation of Revision 01 of the Technical Basis Document for Texas City Chemicals, Inc., Texas City, TX [80 KB (9 pages)]
                Contract No. 75D30119C04183
                Document No. SCA-TR-2020-SP002, Revision 0
                September 21, 2020
NIOSH/DCAS Memo: Texas City Chemicals Review [90 KB (3 pages)]
                May 19, 2020
SC&A Draft: Evaluation of Technical Basis Document for Texas City Chemicals, Inc., Texas City, Texas [440 KB (22 pages)]
                Contract No. 211-2014-58081
                Document No. SCA-TR-2018-SP004
                May 18, 2018
SC&A Draft: A Focused Review of the NIOSH Evaluation Report for the Texas City Chemical Company SEC Petition [300 KB (44 pages)]
            Contract No. 200-2004-03805
            Task Order No. 5
            July 2008Public Comments on Texas City Chemicals, Inc. Documents
How to Submit Comments
Comments on Texas City Chemicals, Inc. Documents can be submitted to the NIOSH Docket Officer electronically by email at nioshdocket@cdc.gov or printed comments can be mailed to:
NIOSH Docket Office
Robert A. Taft Laboratories, MS-C34
1090 Tusculum Avenue
Cincinnati, OH 45226
Please include the Site Profile/Docket Number (112) on all comments.
Comments Received
Letter to the Advisory Board from Congressman Pete Olson, regarding Texas City Chemicals SEC petition (NIOSH SEC-00088) [80 KB (2 pages)]
            October 1, 2010
Letter from the Advisory Board in response to Congressman Pete Olson’s October 1, 2010, inquiry regarding the Texas City Chemicals SEC petition (NIOSH SEC-00088) [160 KB (2 pages)]
                        November 3, 2010
Comments from Daniel W. McKeel, Jr., M.D., on the Texas City Chemicals, Inc., SEC Petition (NIOSH SEC-00088) [85 KB (3 pages)]
            July 26, 2010
Comments from Daniel W. McKeel, Jr., M.D., on the Texas City Chemicals, Inc., SEC Petition Evaluation Report (NIOSH SEC-00088) [94 KB (2 pages)]
            June 24, 2010
Comments from Daniel W. McKeel, Jr., M.D., on the Texas City Chemicals, Inc., SEC Petition (NIOSH SEC-00088) [17 KB (1 page)]
            January 7, 2010Document Archive for Texas City Chemicals, Inc.
SEC Petition Evaluation Report for Texas City Chemicals, Inc. [649 KB (45 pages)]
            January 29, 2008Technical Basis Documents:
Approved November 2, 2017 [633 KB (22 pages)]
							
					
							Last Reviewed:  June 30, 2022						Source: 	National Institute for Occupational Safety and Health
					Facebook
        Twitter
        LinkedIn
        Syndicate homeRadiation Dose ReconstructionAbout DCASThe Act/EEOICPADose Reconstruction (DR)plus iconDataplus iconSourcesFormats & TypesSensitive DataWork History                            Phone CallData Search and Capture EffortsMethodsProductionTechnical Documents Used in Dose ReconstructionsProgram Evaluation Reports and PlansQuality Assurance and Quality ControlSupport ContractorSoftware (IMBA)RECA ClaimsProbability of Causationplus iconCalculating PCNews & UpdatesNIOSH-IREP SoftwareSpecial Exposure Cohortplus iconSubmit a PetitionCheck Petition Statusplus iconSEC Status TableGet HelpResidual ContaminationAdvisory Boardplus iconPublic MeetingsSubcommittee and Work GroupsSEC Petition RecommendationsTechnical Support for the Review of NIOSH Dose Reconstruction ProgramReports from the Advisory Board's Technical Support ContractorTechnical Review Summaries from the Technical Support ContractorProceduresCorrespondenceWork Site InformationPublications & ProductsProgram ReviewsReports to CongressPolicies, Procedures, and GuidelinesNIOSH Public DocketRelated Program LinksContact UsHELPplus iconHelp A – ZAccessibilityAcronymsFrequently Asked Questions (FAQs)plus iconThe ActCase ConcernsClaimant CorrespondenceConflict or BiasDose ReconstructionFreedom of Information Act (FOIA)National Defense Authorization ActNIOSH-IREPProbability of CausationResidual Contamination ReportResponsibilities under Subtitle B of EEOICPA (The Act)Special Exposure CohortTechnical DocumentsWork History Phone CallGlossary Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue